-
Cisapride (R 51619) in Cardiac Electrophysiology Research
2026-05-05
Cisapride (R 51619) is a gold-standard tool for benchmarking hERG channel inhibition and 5-HT4 receptor signaling in cutting-edge cardiac arrhythmia research. Its validated integration with iPSC-derived cardiomyocyte workflows enables reliable, high-content cardiotoxicity screening, minimizing attrition risk in early-stage drug discovery.
-
TFEB-Driven PD-L1 Induction Drives mTORi Resistance in RCC
2026-05-04
Zhang et al. reveal that TFEB promotes immune evasion and resistance to mTOR inhibition in renal cell carcinoma (RCC) by upregulating PD-L1 expression. Their mechanistic insight informs combinatorial immunotherapy strategies targeting both mTOR and PD-L1 pathways.
-
Alcian Blue & Nuclear Fast Red Staining Kit pH2.5: Workflow
2026-05-04
Unlock precise mucopolysaccharide and nuclear visualization with the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5. This guide details experimental workflows, troubleshooting, and the latest research-driven innovations that elevate chondrogenic differentiation and mucin detection in histology.
-
Amphotericin B: Applied Workflows for Fungal Infection Resea
2026-05-03
Unlock the full experimental power of Amphotericin B, the polyene antifungal antibiotic trusted by APExBIO, for advanced fungal infection research. Discover stepwise enhancements, synergy-driven assay design, and troubleshooting rooted in the latest evidence.
-
Nonivamide (Capsaicin Analog): Next-Generation TRPV1 Modulat
2026-05-02
Explore how Nonivamide, a potent capsaicin analog, is redefining TRPV1-targeted cancer research with unique mitochondrial apoptosis dynamics and advanced protocol strategies. Uncover mechanistic insight and practical guidance not found in standard reviews.
-
NLRP10 Regulates Keratinocyte Survival and Differentiation i
2026-05-01
This study establishes NLRP10 as a critical regulator of epidermal homeostasis by supporting keratinocyte survival and p63-dependent differentiation, directly linking reduced NLRP10 expression to impaired skin barrier function in atopic dermatitis. The findings provide a mechanistic basis for novel therapeutic strategies aimed at restoring skin barrier integrity in AD.
-
LY2109761 (TβRI/II kinase inhibitor): Reliable TGF-β Pathway
2026-05-01
This article delivers scenario-driven, evidence-based guidance on leveraging LY2109761 (TβRI/II kinase inhibitor, SKU A8464) for robust modulation of the TGF-β signaling pathway in cancer, radiosensitivity, and fibrosis research. Benchmarked against common laboratory challenges, it highlights workflow optimization, reproducibility, and vendor reliability for biomedical scientists.
-
EIF4A3–circEIF2S2–miR-646/UHMK1 Axis Drives CRC Progression
2026-04-30
This study establishes that EIF4A3-induced circEIF2S2 promotes colorectal cancer (CRC) growth, metastasis, and immune evasion by modulating the miR-646/UHMK1 axis. The findings reveal a novel regulatory pathway and identify circEIF2S2 as a potential biomarker and therapeutic target for CRC.
-
Captopril as an ACE Inhibitor: Applied Protocols and Researc
2026-04-30
Captopril is a benchmark ACE inhibitor for hypertension and cancer research, prized for its high potency and reproducibility. This article translates cutting-edge findings into actionable workflows and troubleshooting strategies, empowering researchers to achieve robust, reproducible results with APExBIO’s Captopril.
-
Aging Lens Epithelium: Ferroptosis Susceptibility and Redox
2026-04-29
Wei et al. reveal that aging human and mouse lens epithelial cells (LECs) are highly susceptible to ferroptosis, a non-apoptotic, iron-dependent cell death. This work provides mechanistic insight into age-related cataractogenesis, highlighting the roles of redox and iron homeostasis and establishing new experimental models for ferroptosis research.
-
PDE-5-Inhibited BMSCs Mitigate Diabetic Myocardial Fibrosis
2026-04-29
This study demonstrates that bone marrow mesenchymal stem cells (BMSCs) with silenced phosphodiesterase-5 (PDE-5) expression can substantially reduce high glucose-induced myocardial fibrosis and cardiomyocyte apoptosis by activating the cGMP/PKG signaling pathway. These findings provide mechanistic insight into a potential cell-based strategy for the prevention and treatment of diabetic cardiomyopathy.
-
Calnexin’s Role in CFTR Variant Rescue and Corrector Sensiti
2026-04-28
Tedman et al. (2025) systematically dissect how calnexin influences CFTR variant expression and pharmacological rescue, revealing domain- and mutation-specific dependencies that shape corrector drug response. Their findings inform the design of personalized modulation strategies and small-molecule screening in cystic fibrosis research.
-
Exercise-Driven Skeletal Muscle EVs Enhance Amyloid Clearanc
2026-04-28
This study reveals that exercise-induced skeletal muscle-derived extracellular vesicles (SKM-EVs) are taken up by microglia, leading to enhanced amyloid-beta plaque clearance and improved cognitive outcomes in Alzheimer's disease mouse models. The findings highlight the myokine-like role of SKM-EVs and identify miR-378a-3p as a key cargo mediating microglial metabolic reprogramming, suggesting a mechanistic bridge between peripheral muscle activity and central nervous system amyloid pathology.
-
Wnt/β-catenin Pathway Drives Soluble PD-L1 Production in Gli
2026-04-27
This study reveals that glioma cells generate soluble PD-L1 through Wnt/β-catenin signaling, directly suppressing CD8+ T cell function and correlating with poor prognosis. The findings highlight sPD-L1 as a minimally invasive biomarker and suggest combined Wnt and PD-L1 inhibition as a strategy to enhance glioma immunotherapy.
-
Tacrine Hydrochloride Hydrate: Translational Leverage in Alz
2026-04-27
This thought-leadership article advances the field by synthesizing the mechanistic foundations, strategic value, and translational guidance for Tacrine hydrochloride hydrate (Tetrahydroaminacrine) in Alzheimer’s disease research. Drawing on contemporary hybridization strategies and positioning APExBIO’s offering as a gold-standard tool, the article bridges molecular insights with actionable experimental workflows and future-facing therapeutic paradigms.